Status:
COMPLETED
Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus
Lead Sponsor:
Novartis
Conditions:
PROTEINURIA
Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This is a study of whether valsartan affects levels of proteinuria in patients with type 2 diabetes and hypertension.
Eligibility Criteria
Inclusion
- \- Mild to moderate hypertension, Mild renal dysfunction, Type 2 diabetes,
Exclusion
- Pregnant or breast feeding, Type 1 diabetes
- Other protocol criteria apply
Key Trial Info
Start Date :
November 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2005
Estimated Enrollment :
392 Patients enrolled
Trial Details
Trial ID
NCT00241085
Start Date
November 1 2002
End Date
August 1 2005
Last Update
November 8 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.